Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $9.4 million versus the consensus estimate of $8.6 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.